Move Over Nvidia, This Custom Chip Stock Could Be the Next Big Winner

Marvell is positioned to benefit from the shift in AI workloads from training to lower-compute inference, driving demand for custom AI processors. The article claims Marvell has 20%-25% share of the custom AI chip market, designs chips for the top hyperscalers, and could address $75B in lifetime revenue opportunities versus ~$8.7B trailing-twelve-month revenue, implying potential growth acceleration. Marvell shares are noted up 144% in 2026, and the piece argues Marvell could outperform Nvidia as Nvidia’s 80% AI chip market share slowly slips amid intensifying competition.

Analysis

The cleanest read is not that NVDA loses the AI war, but that the profit pool is fragmenting from a single platform winner into a multi-vendor architecture. That usually favors the “picks and shovels” layer with better customization exposure and more pricing power than commodity accelerators, which is why MRVL can keep outperforming even if aggregate AI capex merely normalizes rather than accelerates. Second-order beneficiaries are AMZN and MSFT: custom silicon can lower inference cost per query and improve gross margin at scale, but it also increases in-house bargaining leverage versus external chip vendors.

The near-term risk is that the market is extrapolating design-win rhetoric into straight-line revenue. Custom chip ramps are lumpy, customer-concentrated, and subject to qualification delays; one hyperscaler pushout can move the equity more than the underlying demand trend. Over the next 1-3 months, the key catalyst is capex commentary from hyperscalers and any disclosure on networking/optical attach rates; over 6-18 months, the real test is whether inference economics are strong enough to justify continued multi-vendor silicon spend rather than a re-centralization back toward NVDA’s software ecosystem.

Contrarianly, the consensus may be underestimating NVDA’s ability to defend share via platform integration and inference software, while overestimating how quickly MRVL can convert a long pipeline into durable EPS power. After a large rerating, MRVL likely needs perfect execution to justify further multiple expansion; the stock can still work, but the easy money may be behind it. The higher-probability expression is relative value, not outright beta: own the custom-silicon beneficiaries against the premium multiple embedded in NVDA, but only on pullbacks and with a tight catalyst calendar.

Key Decisions for Investors

• Initiate a tactical long MRVL / short NVDA pair on any 3-5% weakness in MRVL, targeting 1-3 month hyperscaler capex updates; thesis is mix shift and custom-silicon share gains, not total AI demand expansion.
• Do not short NVDA outright here; if anything, use NVDA put spreads only around earnings or major data-center events as a hedged way to express multiple compression risk, since platform stickiness can cushion downside.
• Add AMZN and MSFT as second-order beneficiaries on any guidance confirming higher inference efficiency from custom silicon; the trade is margin expansion, with a 6-18 month horizon, not a near-term revenue pop.
• Set a watch item on MRVL customer concentration and design-win conversion: if next quarter does not show improved backlog-to-revenue conversion or networking attach, trim the long because the market has already priced in a strong execution path.